Anika Therapeutics (NASDAQ:ANIK) shareholders have endured a 37% loss from investing in the stock three years ago [Yahoo! Finance]
Anika to Issue First Quarter 2024 Financial Results on Wednesday, May 8, 2024
Anika to Participate in the 23rd Annual Needham Virtual Healthcare Conference [Yahoo! Finance]
Anika to Participate in the 23rd Annual Needham Virtual Healthcare Conference
Anika Therapeutics, Inc. (NASDAQ: ANIK) had its price target raised by analysts at Barrington Research from $29.00 to $37.00. They now have an "outperform" rating on the stock.